SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is currently seeing heightened retail engagement and bullish sentiment, with community members actively discussing potential price reversals and technical patterns. Traders are heavily debating the sustainability of these moves, while long-term holders continue to emphasize ecosystem developments and burn mechanisms as drivers for future growth.

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending as investors monitor the final legal outcome regarding Medicare bundling for Xphozah, while actively discussing the potential for a rerating once the company achieves sustained profitability. The community remains focused on robust Ibsrela sales momentum, upcoming clinical trial readouts, and speculation regarding a potential buyout.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum Inc. is experiencing heightened investor interest and volatility following news that the company secured a significant grant from the National Science Foundation, alongside broader optimism driven by executive actions establishing quantum computing as a national strategic priority. The community is actively debating the stock's future, weighing potential commercialization milestones against concerns regarding valuation, stock dilution, and market manipulation.

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Medtronic Plc

Medtronic is capturing market attention as the company navigates strategic restructuring and board appointments following a significant stake from Elliott Investment Management, while simultaneously leveraging strong procedure demand and new product pipeline momentum. Investors are actively debating the company's long-term growth potential and dividend stability as it balances ongoing innovation in medical devices with broader sector-wide rotation trends.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevron is capturing significant investor attention as hyperscalers increasingly turn to integrated energy majors to secure long-term, on-site natural gas power for AI data center infrastructure. Meanwhile, the stock continues to trade with sensitivity to geopolitical volatility in the Strait of Hormuz, with market participants closely monitoring the interplay between ongoing oil supply constraints and evolving diplomatic negotiations.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust is capturing investor attention as the broader crypto market navigates high-stakes regulatory developments, including the Digital Asset Market CLARITY Act. Community discourse remains heavily focused on institutional inflows and Bitcoin's potential to serve as a macro hedge, despite ongoing debates regarding price volatility and the long-term impact of ETF flows.

Aventus Network

Aventus Network is gaining community attention as investors discuss its enterprise-focused infrastructure, decentralised compute layer, and recent ecosystem developments. The community is actively debating the potential for increased momentum and adoption as the project continues to expand its node economy.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is seeing intense community speculation as investors anticipate a pivotal Phase 3 IZAR-1 readout for its lead drug, sonelokimab, which many view as a potential blockbuster for psoriatic arthritis and hidradenitis suppurativa. Discussion is heavily focused on potential M&A activity, with retail investors and institutional interest centered on the stock's undervaluation relative to competitive trial results and the possibility of a lucrative buyout by major pharmaceutical players.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is experiencing heightened volatility driven by the shifting geopolitical conflict between the U.S. and Iran, with traders debating whether ongoing diplomatic efforts signal a meaningful de-escalation or merely a temporary pause. The community remains deeply divided, with bulls pointing to potential relief rallies and positive signals from futures, while bears emphasize systemic risks, inflationary pressures from energy prices, and the unsustainable nature of current market valuations.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is seeing intense community debate over its long-term commercial strategy following its recent acquisition of Melinta Therapeutics and the expiration of TDAPA reimbursement. Investors are actively scrutinizing management's execution of DefenCath adoption, the potential for legislative support via K-CAPA, and the impact of upcoming quarterly earnings on share price stability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sberbank Russia PJSC provides commercial banking and financial services. The company engages in corporate and retail banking activities, such as corporate loans, asset management, payroll projects, leasing, online banking, cash and settlement services, among others. In addition, the company offers a wide range of services to financial institutions, such as correspondent accounts, custody services, and interbank lending, among others. It operates through the following segments: Moscow, Central and Northern Regions of European Part of Russia; Volga Region and South of European Part of Russia; Ural, Siberia and Far East of Russia; and Other Countries. The company was founded in 1841 and is headquartered in Moscow, Russia.

Sberbank of Russia. - ADR

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards another losing week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

SBRCYSBERBANK RUSSIA/S ADR

Fundamentals

Latest SBRCY News